1. Home
  2. EVI vs TNXP Comparison

EVI vs TNXP Comparison

Compare EVI & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

N/A

Current Price

$15.70

Market Cap

204.6M

ML Signal

N/A

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$12.70

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVI
TNXP
Founded
1959
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
199.7M
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
EVI
TNXP
Price
$15.70
$12.70
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
120.3K
448.1K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
1.81%
N/A
EPS Growth
32.43
91.75
EPS
0.31
N/A
Revenue
$389,830,000.00
$13,107,000.00
Revenue This Year
$15.53
$558.11
Revenue Next Year
$3.83
$38.29
P/E Ratio
$50.61
N/A
Revenue Growth
10.26
29.85
52 Week Low
$13.75
$9.40
52 Week High
$34.82
$39.45

Technical Indicators

Market Signals
Indicator
EVI
TNXP
Relative Strength Index (RSI) 57.33 59.67
Support Level $15.61 $11.98
Resistance Level $17.59 $13.36
Average True Range (ATR) 0.88 0.85
MACD 0.24 0.21
Stochastic Oscillator 68.60 72.75

Price Performance

Historical Comparison
EVI
TNXP

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: